{"name":"Xilio Development, Inc.","slug":"xilio-development-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"XTX202","genericName":"XTX202","slug":"xtx202","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"XTX202","genericName":"XTX202","slug":"xtx202","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxORnNFT1N3dTFMdVhHSVZmUDlsVWZPNHJfckJ3Z2ZSakgxY1c2WTA0UmpOSFJtWW9qam1SamF5bl90RHFTQ3J0QW9qV2Z4SXU0VW5PeWhIa21KVm1Fem1lVDBmZTA0Wjc2N1RKZmViQno0b1QwYnFQMHZQLUpBZmQ4bWlxajhyLU1pc1dfYWU1WUVTOUw5V2FERGNFY1lDR1Q0UEg4bmJxZERZUWM4?oc=5","date":"2026-03-23","type":"deal","source":"Stock Titan","summary":"Xilio Therapeutics (XLO) outlines masked immuno-oncology pipeline and big pharma deals - Stock Titan","headline":"Xilio Therapeutics (XLO) outlines masked immuno-oncology pipeline and big pharma deals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQbXdHdzEzcjhGOE8ydTN2T3BSekNGalJITnV6XzJMd1Jxb1plWXF2LXlKSkFHMk5vM0tUaC01NDZ5SWY3OWhBNVg2Y2w3Z3NzakVhbk1CZERMYjlkalNVVUNCR0U4aEdyTGhtZVgtWGxPUVJ1akt3VlFkbURMRE5rNkR2N3hJMUF0dF9fU01tWmJlU2lzWkhSOWZkdFlSZk1kblhDMmRoMFM4aXMxNy1z?oc=5","date":"2026-03-23","type":"earnings","source":"Stock Titan","summary":"Xilio (NASDAQ: XLO) boosts 2025 revenue and cash runway into 2027 - Stock Titan","headline":"Xilio (NASDAQ: XLO) boosts 2025 revenue and cash runway into 2027","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTFByMXVXQ29USHlfckRvd1ZDUGNkcENLaGF0N09sTDNLN3V6UVNWcGpjdlFfNFIzUXo4cHBhY2lCZE1kSFVPQmJGOXdmQV9wNnExOEpaN016RWlvUWxKcWlRQUhsV0RHT19BWHRoUA?oc=5","date":"2026-03-22","type":"pipeline","source":"Stock Titan","summary":"If You Invested $1,000 in Xilio Therapeutics, Inc. (XLO) - Stock Titan","headline":"If You Invested $1,000 in Xilio Therapeutics, Inc. (XLO)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQak1tOEd4bHk4MG0zb2gzYWJXano4OEJ0QVk4NEtJNlF4ajBhQXYzYnlMSjVWQkpkUFd1NVlPTmVXY3dBRWxIdWthMlhiMnpDd3pKbnFkTktZNHpqTlBlQk9tcWptTmN2a3RGMkh1MlZma2VsejlFaXotZzF5czNCQ1NKazE0a0NQRmtpQTRmRmdyOTdET0daUVVUMlV3RWpfNFRsdjNERlNxRVk?oc=5","date":"2026-03-17","type":"pipeline","source":"Quiver Quantitative","summary":"Xilio Therapeutics to Present Poster on XTX601 at AACR Annual Meeting 2026 - Quiver Quantitative","headline":"Xilio Therapeutics to Present Poster on XTX601 at AACR Annual Meeting 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxQOUJmOURpYXZoYTJyYUdGdndLWUswZkFIak9KU0w5cVJPQmliOEF5NVc1MEsyTm5HbEJ1bFQyRnMwMF9CUFFQeVBlRHVOX0hxMVp2VlhpY1RBSUtnRlk0WUFjeWZodTdkckgwQWhRZHBNdDZPMHphaUtNdkN6aU5ROXBIcUlZZmlBNjVwZ2ZFWGMwREs1NkN5WEVwZnZnck1PZzVSUzNaRDItS2ZtaFlDdEdHMDY5andxUDRFTUd4dE10TlNaOWlSRA?oc=5","date":"2026-03-12","type":"pipeline","source":"globenewswire.com","summary":"Xilio Therapeutics Announces 1-for-14 Reverse Stock Split - globenewswire.com","headline":"Xilio Therapeutics Announces 1-for-14 Reverse Stock Split","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxNUkQtVm9DMVNkX2gxaUpzWXNRc0VxUEVGWFBDUUtVVk11bHg4SHUwNlFZeWRxeVVkcDI1ZEVqQjV6VWJYSFI3VC1wN3NPTUNRVjZkMmxsVEhDQ2JLRHA3b3ptdU9JVFhNcWpTOWZKYXVqTU9PLWY3di02RUs0UUd2OHdQU3J3MjQzUlZSSHZUbDlteUxsUXF3TDBDVnl3RDJiS3ZDcWlhTVBEM1JBbUtxajhOaUZ3ZmRQSEFOTFZCbE5ub0dsYXFnZjg3LXFPQQ?oc=5","date":"2026-02-11","type":"pipeline","source":"globenewswire.com","summary":"Xilio Therapeutics Announces Pricing of Underwritten Offering - globenewswire.com","headline":"Xilio Therapeutics Announces Pricing of Underwritten Offering","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxOaXFRMVN3ckRfdUhtN2VXNUdQTF93RlJqaEhGS251cjJvVjBaZ1R6RVBadkM3dDh2NDBTX2FZdmtYNVRjNUhLSkswRF9xZFZPQnFRNjlTVWtmZjgyTkw0WFUwYXVMbkEtUVZNYmM3cTY2YjFoaUw2bmxoeTFkVktJbWd3?oc=5","date":"2025-02-13","type":"pipeline","source":"Pharmaceutical Technology","summary":"AbbVie and Xilio to collaborate on antibody-based immunotherapies - Pharmaceutical Technology","headline":"AbbVie and Xilio to collaborate on antibody-based immunotherapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigJBVV95cUxORkptU2c5SlJpS1R2ZzFRLVAwT19sX1FUUjB3a09fc1N5ZElHR1NDZEpZczJ3cWpPWVlycDAxSV9DcXVmemM1R2JRNW9ZUDh5OFZRWXoyZnlNWnhNYkRNRXJRZ2RRZDhCWmJZTHJoX2FGZlF3Z0owTmZtbUpqZzNQOElIM01KTFlFR2RlMy15dnhqWkdZR0V3OTFfVlpHQlRhNHl0eVVrZ2xWN1Y0MnJDYlBGcWRncUt0Q29QWWc1aHNkR2c2QWoxM0hkckpwNUlNcXpxT1FsQ1dPRnR1bklnMWdsRHE5ZnpycWxYMWpPNWZmMHFmbnZISExlMzZqTkhYMnpfRlBHcnctdw?oc=5","date":"2025-02-12","type":"deal","source":"PR Newswire","summary":"AbbVie and Xilio Therapeutics Announce Collaboration and Option Agreement to Develop Novel Tumor-Activated Immunotherapies - PR Newswire","headline":"AbbVie and Xilio Therapeutics Announce Collaboration and Option Agreement to Develop Novel Tumor-Activated Immunotherapi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQeUIwbnNzN3VDRDRxWFhqSXdSNHVydTdPYlRGVF9zdUVZSXpQSlBSX041aUZmbEdEUTE5bW45aktYeDNQMXJfY1dPY1NTQWhHWjdZNzl1Y3FFLUhtSU5xVktwUWdDREVZcVZ3dkNaQ0ZIcE9YeHJnYklMWW9pSDliUTBtYUNJY2pfYXJ5Y21TcmRyRmhJMmd4UHdR?oc=5","date":"2025-02-12","type":"deal","source":"Fierce Biotech","summary":"AbbVie signs heavily backloaded $2.1B Xilio biobucks pact in Big Pharma's latest T-cell engager deal - Fierce Biotech","headline":"AbbVie signs heavily backloaded $2.1B Xilio biobucks pact in Big Pharma's latest T-cell engager deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPRVFhdDdzZ25odlVUVHhhek1KLXEwbjByQmItME9sdEN3clJuWmNPVDZ3NWxHbWZPQ3pzNTRvSnV0WGtFMkNNZndxaW91ZzEwUWl1OERJQkRvTzFnUU1YZURVN1ZWWlh3Z1VVWVZaWk5fWm81TE5aeDlaRmF4OEZwWVB2ZHQzd0puLVZWZ1BkZmc5QVRFd2gwa1VMM1JhQQ?oc=5","date":"2025-02-12","type":"deal","source":"Crain's Chicago Business","summary":"AbbVie inks another billion-dollar oncology deal - Crain's Chicago Business","headline":"AbbVie inks another billion-dollar oncology deal - Crain's Chicago Business","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxORUw3UW5yN3lvR3BNbUNOWHl0eExhOHdoNF9SdFl4dEQ5U1gwSzhtSTdyRU1ETUs1aGVuVzVvYndaTW5WMDJDQVR0SUhJQ0tDR1hnd1V0THZzZ2VWTkhFYnVMSnZRbXlJS1JFY2RoMDg2eUpveFBFbjgzYi04RHNpdDJ3NlROemdfT3ZVTjlUcFk?oc=5","date":"2024-03-28","type":"pipeline","source":"BioPharma Dive","summary":"Gilead bets on Xilio cancer drug as biotech restructures - BioPharma Dive","headline":"Gilead bets on Xilio cancer drug as biotech restructures","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQcnpqbDJ6OXZzVDlxOXRqVzdwQ1N0dDFYUk9mcnQtUm1LVjBvaFhwZ19hZWc1VW1LMDZkRjRJamt0RFhXc1JkSl8xcHBMX1VvOW8ta21VNDhkdElzTE0tQzdIQlVOMWZwNFlwaFFfYzNfcVA2VFo5OTZucTBRc1Q3ZG03RFFNaEVzdnpfOWFtZ0UtbTVuUlZudko0bUdTbHIwMU80QVpRMmhXZ2ZR?oc=5","date":"2021-10-24","type":"pipeline","source":"MedCity News","summary":"Xilio, Ventyx IPOs raise $269M to fuel plans to compete with big pharma drugs - MedCity News","headline":"Xilio, Ventyx IPOs raise $269M to fuel plans to compete with big pharma drugs","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}